This study provides evidence on the mix of government and non-government direct and indirect funding in the homelessness service system and across mainstream services and enterprises supporting the homeless and examines how the funding of homelessness services influences service provision and out
In this study, we will undertake detailed analyses of the largest cross-national epidemiologic study of mental and substance use disorders ever conducted. The WHO World Mental Health Survey (WMHS) initiative is a massive, unique endeavour.
There has been a dramatic increase in opioid prescribing in Australia. This increase has been associated with increased harms including opioid dependence and overdose.
The Comorbidity and Trauma Study (CATS) is a large retrospective case-control study, which examined the influence of genetics and environmental factors (e.g. childhood trauma) contributing to opioid dependence liability.
The evidence of methadone maintenance treatment's (MMT) impact on reducing crime and other harms is overwhelming, yet its implementation is limited in the community and in prison.
Common Ground Sydney opened on 15 November 2011 and is Australia’s third project based on the Common Ground model. Common Ground Sydney accommodates formerly chronically homeless people and people on low to moderate incomes in a socially integrated housing complex in inner Sydney.
This project aimed to develop and test the first highly interactive, comprehensive, and evidence-based smartphone app for treating cannabis use.
This study examines the utilisation of opioid substitution therapy among a large community sample of chronic non-cancer pain patients receiving long-term opioid substitution therapy (OST).
Smoking cessation rates need to improve among low-socioeconomic status (low-SES) Australians if we are to reach a key national target as the health country: ≤ 9% smoking by 2020 . Recent (2013) National Drug Strategy Household Survey data show that persons from disadvantaged areas are three
This is a feasibility study to test the effectiveness of cannabidiol (CBD) for alleviating cannabis withdrawal symptoms in a 6 night inpatient detoxification program.
